These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 10224382)
1. Do Tr1 cells play a role in immunotherapy? Saloga J; Bellinghausen I; Knop J Int Arch Allergy Immunol; 1999; 118(2-4):210-1. PubMed ID: 10224382 [No Abstract] [Full Text] [Related]
2. Immunotherapy: readdressing the balance between TH2 and TH1 cells. Till S Clin Exp Allergy; 1997 Sep; 27(9):981-5. PubMed ID: 9678826 [No Abstract] [Full Text] [Related]
3. Importance of the inducible costimulator molecule for the induction of allergic immune responses and its decreased expression on T helper cells after venom immunotherapy. Bellinghausen I; Klostermann B; Böttcher I; Knop J; Saloga J Immunology; 2004 May; 112(1):80-6. PubMed ID: 15096187 [TBL] [Abstract][Full Text] [Related]
6. Do allergens induce type-2 immune responses? Comoy E; Pestel J; Stewart GA; Finkelman F; Capron A; Thyphronitis G Int Arch Allergy Immunol; 1999; 118(2-4):399-402. PubMed ID: 10224458 [No Abstract] [Full Text] [Related]
7. Sublingual immunotherapy of allergic diseases. Werner-Klein M; Kalkbrenner F; Erb KJ Expert Opin Drug Deliv; 2006 Sep; 3(5):599-612. PubMed ID: 16948556 [TBL] [Abstract][Full Text] [Related]
8. [Allergen-specific immunotherapy (hyposensitization). Part 1. Basics and subcutaneous application]. Klimek L HNO; 2000 Jan; 48(1):59-67. PubMed ID: 10663053 [No Abstract] [Full Text] [Related]
9. [Applicable strategies for the mucosal immune system in the regulation of allergic diseases]. Kurashima Y; Kunisawa J; Kiyono H Arerugi; 2008 Feb; 57(2):87-94. PubMed ID: 18349582 [No Abstract] [Full Text] [Related]
10. Expression of Th1, Th2, lymphocyte trafficking and activation markers on CD4+ T-cells of Hymenoptera allergic subjects and after venom immunotherapy. Cabrera CM; Urra JM; Alfaya T; Roca Fde L; Feo-Brito F Mol Immunol; 2014 Nov; 62(1):178-85. PubMed ID: 25004111 [TBL] [Abstract][Full Text] [Related]
11. Mechanisms of specific immunotherapy of allergic diseases. Kowalski ML; Jutel M Allergy; 1998 May; 53(5):485-92. PubMed ID: 9636807 [No Abstract] [Full Text] [Related]
12. Redirecting Th2 responses in allergy. Parronchi P; Maggi E; Romagnani S Curr Top Microbiol Immunol; 1999; 238():27-56. PubMed ID: 10087649 [No Abstract] [Full Text] [Related]
13. [DNA vaccines to allergic diseases and upcoming clinical application]. Sano K Nihon Rinsho; 2005 May; 63 Suppl 5():73-9. PubMed ID: 15954328 [No Abstract] [Full Text] [Related]
14. Sublingual immunotherapy mechanisms of action: the role of Th1 response. Ciprandi G; Tosca MA; Marseglia GL Int J Immunopathol Pharmacol; 2009; 22(4 Suppl):9-12. PubMed ID: 19944003 [TBL] [Abstract][Full Text] [Related]
15. Role of type 2 T helper cells (Th2) in allergic disorders. Parronchi P; Sampognaro S; Maggi E; Romagnani S Adv Exp Med Biol; 1996; 409():359-63. PubMed ID: 9095266 [No Abstract] [Full Text] [Related]
16. Early dog exposure: potential pathways to allergic disease. Wright AL Clin Exp Allergy; 2008 Oct; 38(10):1568-71. PubMed ID: 18647316 [No Abstract] [Full Text] [Related]
17. T cells and allergens relationships: are they that specific? Botturi K; Vervloet D; Magnan A Clin Exp Allergy; 2007 Aug; 37(8):1121-3. PubMed ID: 17651139 [No Abstract] [Full Text] [Related]